← Leaderboards
Edouard M Cantin
City Of Hope/Beckman Research Institute
$4,721,467
Attributed
$4,721,467
Total exposure
6
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $437.5K · FY2005–17$500K$375K$250K$125K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
Funding mix
By agency
NIH$4,721,467 · 6
By mechanism
R01$3,007,219 · 2
R21$1,294,248 · 3
R56$420,000 · 1
Top collaborators
No co-investigators on record.
Others in their field
Top investigators on “Immunity”
- Lawrence Corey · Fred Hutchinson Cancer Center$680,290,567
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$541,067,641
- Bambra Strokes · Ppd Development Lp$526,656,217
- Barton F Haynes · Duke University$470,748,611
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$342,310,423
- Judith S. Currier · University Of California Los Angeles$334,425,492
Research focus
ImmunityInfectionInflammatory ResponseInflammationInflammatoryLaboratory MouseNeuronsLatent InfectionCorneaVirus ReplicationSimplexvirusEncephalitisKeratitisPreventLesionVirusGender DifferenceAffectHerpes Simplex Virus 1ImmuneBrainHerpesvirus 1, HumanMediatingBioinformatics
Grant awards (14)
Role for the Microbiota in Development of Herpes Stromal Keratitis$249,975
R21 · FY2017 · EY · contact PI
Role for the Microbiota in Development of Herpes Stromal Keratitis$226,023
R21 · FY2016 · EY · contact PI
Immunotherapy Ameliorate Neurological Deficits in Encephalitis$212,500
R21 · FY2015 · NS · contact PI
Immunotherapy Ameliorate Neurological Deficits in Encephalitis$253,750
R21 · FY2014 · NS · contact PI
TNF SIGNALING IN THE ABSENCE OF FUNCTIONAL TNF RECEPTORS.$420,000
R56 · FY2012 · AI · contact PI
Mechanisms of IVIG Protection in Viral Encephalitis$415,000
R01 · FY2010 · AI · contact PI
Mechanisms of IVIG Protection in Viral Encephalitis$415,000
R01 · FY2009 · AI · contact PI
A Genetic Determinant of Resistance to HSV$427,219
R01 · FY2006 · EY · contact PI
A Genetic Determinant of Resistance to HSV$437,500
R01 · FY2005 · EY
A Genetic Determinant of Resistance to HSV$437,500
R01 · FY2004 · EY
A Genetic Determinant of Resistance to HSV$437,500
R01 · FY2003 · EY
A Genetic Determinant of Resistance to HSV$437,500
R01 · FY2002 · EY
MECHNISM OF HERPES ST ROMAL KERATITIS$176,000
R21 · FY2001 · EY
MECHNISM OF HERPES ST ROMAL KERATITIS$176,000
R21 · FY2000 · EY